Page last updated: 2024-10-31

deoxyepinephrine and Hodgkin Disease

deoxyepinephrine has been researched along with Hodgkin Disease in 1 studies

Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Marchese, A1
Giuffrè, C1
Miserocchi, E1
Cicinelli, MV1
Bandello, F1
Modorati, G1

Other Studies

1 other study available for deoxyepinephrine and Hodgkin Disease

ArticleYear
Severe Hypotony Maculopathy in Anterior Uveitis Associated with Hodgkin Lymphoma.
    Ocular immunology and inflammation, 2021, Apr-03, Volume: 29, Issue:3

    Topics: Administration, Ophthalmic; Adult; Coloring Agents; Deoxyepinephrine; Female; Fluorescein Angiograph

2021